Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD-OH: Cannabidiol for Severe Alcohol Use Disorder
NCT05860699Phase 2Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2024
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in alcohol use disorder (AUD), sponsored by Assistance publique - Hôpitaux de Paris. Started Apr 2024; status: recruiting.
02
Drugs
cannabidiol
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05860699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05860699.